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Abstract
Effective community-based actions are urgently needed to combat the ongoing epidemic of opioid 
overdose. Community readiness (CR) has been linked to communities’ support for collective 
action, which in turn has been associated with the success of community-wide prevention 
strategies and resulting behavior change. Our study, conducted in North Carolina, assessed the 
relationship between CR and two indices of opioid overdose. County-level data included a survey 
of health directors that assessed CR to address drug overdose prevention programs, surveillance 
measures of opioid overdose collected from death records and emergency departments, and two 
indicators of general health-related status. We found that counties’ rates of CR were positively 
associated with their opioid-related mortality (but not morbidity) and that this relationship 
persisted when we controlled for health status. North Carolina counties with the highest opioid 
misuse problems appear to be the most prepared to respond to them.
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INTRODUCTION
In the first 15 years of the 21st century in the United States, deaths from opioids comprising 
both prescription opioid pain relievers and heroin more than doubled, reaching 9.0 per 
100,000 in 2014 (Rudd, Aleshire, Zibbell, & Gladden, 2016). In 2015, over 33,000 deaths 
were attributed to opioid overdoses; as opioid overdose rates show little sign of abating, the 
Centers for Disease Control and Prevention (CDC) has called for urgent and effective 
actions to combat this epidemic by means of a “multi-faceted and coordinated approach” 
(Rudd, Seth, David, & Scholl, 2016).
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It is generally recognized that the communities affected by the epidemic play a role that is 
essential for meaningful and lasting change (Merzel & D’Afflitti, 2003). Strategies that 
communities may implement, often through the work of coalitions constituted for this 
purpose, include the reduction of stigma associated with the abuse of prescription pain 
medication and heroin; advocacy for change in physicians’ and pharmacists’ prescribing and 
dispensing policies; the organization of pill drop boxes and take-back days; the 
dissemination of the rescue medication naloxone, together with instruction about its 
appropriate administration to reverse opioid overdoses; and increases in local capacity for 
both inpatient and outpatient opioid addiction treatment services (Albert et al., 2011; 
Wheeler, Davidson, Jones, & Irwin, 2012). In North Carolina, our study’s setting, these 
efforts are typically supported, and often led, by county-level health directors (Lancaster, 
McKee, & Mahan, 2013). However, one factor that may impede the successful 
implementation of these strategies is a community’s potential lack of readiness to effect 
change. If that readiness is lacking in communities that have been greatly affected by the 
opioid overdose epidemic, the likelihood that they will come together to take effective action 
may be attenuated. However, the relationship between a community’s readiness to address a 
given public health problem and the severity of the problem is presently unknown. The goal 
of our study was to increase our understanding of the extent to which communities with 
varying levels of opioid misuse and overdose are prepared to respond to the opioid epidemic
BACKGROUND
Community readiness (CR) may be defined as the various attributes of a community’s 
context or ecology that constitute a prerequisite to the implementation of effective change, 
particularly the community’s pertinent knowledge and attitudes and its capacity to 
implement change strategies (Beebe, Harrison, Sharma, & Hedger, 2001; Chilenski, 
Greenberg, & Feinberg, 2007). One model, developed by the Tri-Ethnic Center for 
Prevention Research at Colorado State University, suggests that CR proceeds through nine 
stages that are analogous to those experienced by individuals as they contemplate and then 
implement strategies related to health (Prochaska & Velicer, 1997). For a community, these 
strategies range from “no awareness” of the nature or extent of a problem at one extreme to a 
“high level of community ownership” of solutions to the problem at the other (Brackley et 
al., 2003; Edwards, Jumper-Thurman, Plested, Oetting, & Swanson, 2000). The CR model is 
based in part on the transtheoretical model of the stages of health behavior change 
(Prochaska & Velicer, 1997) and on diffusion of innovation theory (Rogers, 2010). CR 
assessments have been included in health promotion and prevention initiatives targeting a 
variety of health concerns, including obesity (Sliwa et al., 2011), substance abuse (Ogilvie et 
al., 2008), physical activity (Jones, Settipalli, Goodman, Hootman, & Goins, 2012), intimate 
partner violence (Brackley et al., 2003), breast health (Borrayo, 2007), and HIV prevention 
(Thurman, Vernon, & Plested, 2007).
In addition to the assessment tool, the Tri-Ethnic model provides suggestions for activities to 
increase CR levels based on the community’s specific stage. Knowing a community’s stage 
of readiness relative to each dimension, as well as its overall CR, can be helpful in 
prioritizing which activities are most appropriate at different points of time in the change 
process and in leveraging available resources to facilitate change. As such, the CR model is 
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designed to be used as both a practice and a research tool (Donnermeyer, Plested, Edwards, 
Oetting, & Littlethunder, 1997; Edwards et al., 2000).
CR has been linked to communities’ resistance to or support for change and has been 
associated with the success of communitywide prevention strategies and resulting systems 
and behavior change (Chilenski et al., 2007; Feinberg, Greenberg, & Osgood, 2004). We 
sought to contribute to the limited research concerning a community’s readiness to respond 
to a given health problem by assessing the relationship between CR and two indices of a 
community’s epidemic of prescription drug overdose: mortality and morbidity. We reasoned 
that communities experiencing high levels of this epidemic, which affects broad segments of 
the population (Bohnert et al., 2011), would be the most aware of its nature, extent, and 
effects. We thus hypothesized that these communities would demonstrate the greatest 
readiness to combat it by implementing prescription drug overdose prevention strategies. We 
reasoned further that CR in this regard would be sufficiently robust that it would be 
unaffected by other local health-related conditions that might independently affect the 
community’s readiness to engage in collective action. We thus also hypothesized that the 
relationship between CR and measures of the opioid epidemic would persist even when we 
controlled for county-level contextual measures of health and quality of life.
METHOD
Setting
North Carolina is a predominantly rural state with a population of 9.7 million residents as of 
2012. The overall annual state mortality rate for unintentional/undetermined intent 
prescription and opioid-related overdoses was 8.30 deaths per 100,000 population (North 
Carolina Department of Health and Human Services, Division of Public Health, Chronic 
Disease and Injury Section, 2016). Corresponding county-level overdose mortality rates 
ranged from none to 28.4. The suspicion that North Carolina was entering the now well-
established epidemic of drug overdoses began as early as 2002 (Sanford, 2004). By 2007, 
county public health departments had begun identifying the prevention of drug overdose as a 
primary public health concern and the state legislature had passed legislation to develop a 
statewide prescription drug monitoring program.
For this study, we superimposed four North Carolina county-level data sets: (1) a survey of 
county health directors assessing CR to address drug overdose prevention programs in North 
Carolina, surveillance measures of opioid overdose collected from (2) death records and (3) 
emergency departments (EDs), and (4) two indicators of general health-related factors from 
public use data sets described below. All data sets pertained to the State’s counties as of 
2012, prior to the initiation by Community Care of North Carolina of the Chronic Pain 
Initiative (Project Lazarus; https://www.communi-tycarenc.org/population-management/
chronic-pain-project/). This initiative comprises a set of strategies, based on the Project 
Lazarus model of opioid overdose prevention (Albert et al., 2011), that includes the 
development and support of community coalitions as a means to advocate for, implement, 
and sustain a reduction in overdoses from opioid pain medications and heroin. The primary 
data collection presented below was conducted as baseline data for an ongoing evaluation of 
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the statewide rollout of a set of both community- and provider-based overdose prevention 
strategies.
Measures
To assess counties’ CR for prescription drug abuse prevention, we adapted an instrument 
originally developed by the Tri-Ethnic Center for Prevention Research (Plested, Edwards, & 
Jumper-Thurman, 2006), which was designed to be applied to a variety of content areas. The 
original instrument comprised generic semistructured questions that the Center intended to 
be administered to multiple key informants in each community, the results of which were 
then aggregated to determine the level of readiness of each community to engage in a given 
prevention strategy. As conceptualized by the developers, CR comprises six dimensions, 
each of which is measured by means of a hierarchical 9-point ordinal scale that includes 
response options that are tailored to that dimension. The overall CR score constitutes an 
average of the individual scores for each dimension.
In our study, we defined “community” as a county-level health jurisdiction. We used only 
one key informant per county, its health director. We asked respondents to specify their 
county’s level of readiness to prevent prescription drug abuse relative to each of the six 
dimensions of the CR model, instructing them to “please choose the statement that most 
accurately captures the current state of your jurisdiction.” Table 1 displays the six 
dimensions of the CR model, as well as the response options that served as anchors for the 
lowest (1) and highest (9) of the nine levels constituting each dimension (Jumper-Thurman, 
Plested, Edwards, Helm, & Oetting, 2001).
As specified by the developers of the CR model, key informants need only to be 
knowledgeable concerning the status of their community with regard to a particular problem 
of interest; they do not need to play a leadership or decision-making role in the community 
(Edwards et al., 2000). While the scale was originally developed as an interview-based 
instrument, we converted it to a Web-based survey for ease and accuracy of administration. 
We then e-mailed links to the survey to all 87 of the directors in 2012, of whom 69 (79%) 
returned completed surveys. Note that because the catchment areas of five of the responding 
health departments comprise a combined total of 14 counties, these 69 jurisdictions 
represent 78 of the State’s 100 counties. Our adapted instrument is available on request from 
the first author.
To measure rates of ED visits attributable to opioid misuse, we used data from the North 
Carolina Disease Event Tracking and Epidemiologic Collection Tool (NC DETECT; http://
www.ncdetect.org/), which includes data on admissions to all 24/7, acute care, and civilian 
hospital–affiliated EDs in North Carolina. NC DETECT, which is supported by the North 
Carolina’s Division of Public Health, comprises a statewide syndromic surveillance system, 
of which the ED visit data are one component. It is designed to detect salient medical events 
in a timely fashion that can be used for tracking and other epidemiological purposes. We 
identified ED data pertaining to county-level opioid overdose-related visits by the following 
ICD-9-CM (International Classification of Diseases, 9th revision, Clinical Modification; 
CDC, 2016a) diagnostic and external cause of injury codes: 965.0 (.00–.09), E850.0-E850.2, 
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and E935.0. Note that these data pertained to the patient’s county of residence at the time of 
the visit.
We secured mortality data concerning North Carolina residents whose deaths occurred in 
2012 and were attributable to medications and opioids from the State’s vital statistics (CDC, 
2016b). Considered as cases were those residents whose underlying cause of death was an 
unintentional or undetermined drug overdose (i.e., ICD-10 [ICD, 10th revision, Clinical 
Modification]; CDC, 2016b] codes X40–X44, and Y10–Y14). Deaths specifically due to 
opioids were identified by T-codes.
To control for contextual health-related variables, we used aggregated scores related to two 
key constructs from the 2012 Robert Wood Johnson Foundation (RWJF) County Health 
Rankings (RWJF & University of Wisconsin Population Health Institute, 2015) for North 
Carolina. The first, health outcomes, assessed the present level of the overall health of 
county residents. This measure comprised length and quality of life, which included 
indicators of physical and mental health and low birth weight. The second, health factors, 
assessed the likely future health of county residents. Health factors comprised health 
behaviors, which included tobacco use, diet and exercise, alcohol and drug use, and sexual 
activity; clinical care, including access to and quality of care; social and economic factors, 
including education, employment, income, family and social support, and community safety; 
and physical environment, including air and water quality, housing, and transit. Scores for 
each county-level indicator were drawn from a variety of national data sources; further 
information about the scores representing each indicator and the methods by which they 
were aggregated may be found at www.countyhealthrankings.org.
Analysis
We began by aggregating data from all four county-level data sets into a single database, 
including the health director survey, mortality and ED visit data relating to opioid overdose, 
and the RWJF file related to health indicators. Note that in the case of the five health 
directors who were responsible for a total of 14 counties (i.e., four departments each 
represented three counties, and one department represented two), we duplicated their CR 
scores across the counties within their jurisdictions. We converted all mortality and ED visit 
data to rates based on total county population as of 2012, as assessed by U.S. Census data 
(CDC & National Center for Health Statistics, 2016).
We next developed a Pearson product–moment correlation matrix of all study variables. As 
did Paltzer, Black, and Moberg (2013), we treated CR as a continuous variable to allow the 
mean of all six CR components to be compared across counties. We assessed statistical 
significance by means of correlation coefficients.
We then used an ordinary least squares regression to create and assess two discrete models 
that regressed ED visit rates and mortality on mean CR scores. Because of the high level of 
collinearity of the two health indicator variables, as reported in the next section, we only 
used a single RWJF county health ranking measure to adjust for the overall differences 
between counties’ health statuses. We assessed model fit using the R2 statistic and both 
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Akaike information criterion and Bayesian information criterion. We performed all analyses 
using Stata/IC 13.1 (StataCorp, 2013).
All study procedures were approved by the institutional review board of the University of 
North Carolina.
RESULTS
Table 2 displays tests of the strength of the bivariate associations of all study variables. We 
found a small and nonsignificant association between health directors’ mean total CR scores 
and their counties’ overdose mortality rates (r = .16, p =.17, degrees of freedom = 78). We 
also found significant positive relationships between health directors’ mean CR scores and 
both RWJF’s outcome- and factor-related health indicators. That is, counties with a high 
length and quality of life, and positive indicators of physical and mental health, were more 
likely to score high on total community readiness for change.
We concluded our analyses with two linear regression models, the results of which are 
displayed in Table 3. These models assessed the association between health directors’ mean 
CR scores and their counties’ (1) mortality rates and (2) ED visit rates, controlling for 
RWJF’s county health outcomes ranking. The bivariate association between health directors’ 
mean CR scores and opioid overdose mortality rates persisted (β = 1.21, p = .046) in this 
multivariate context, and the relationship between mean CR score and ED visit rate 
continued to be nonsignificant (β = 1.55, p = .423). These models further supported, and 
indeed strengthened, the initial association we found between mean CR score and opioid 
overdose mortality, and no association between the CR score and ED visits for overdose. 
Note that when we substituted RWJF’s outcome with factor scores in our regressions the 
results of the models did not change.
DISCUSSION
Our study results only partially validated our hypothesis; counties’ rates of CR were 
positively associated with their opioid-related mortality (but not morbidity). Counties with 
high rates of opioid-related mortality were also more likely to score high on their health 
directors’ ratings of their residents’ knowledge of their counties’ opioid overdose problems. 
These findings are encouraging, insofar as they suggest that the communities in high-risk 
counties seem prepared to select and implement prevention strategies such as those 
promoted by Project Lazarus (Albert et al., 2011), which is designed to build capacity and 
infrastructure and to raise awareness. We should note, however, that the evidence supporting 
our first hypothesis was mixed, in that we did not find an analogous relationship between 
CR and opioid-related ED visits. This finding led us to speculate why their relationship was 
all but nonexistent.
While statistically significant, the association between our two measures of county-level 
opioid overdose rates, mortality and ED visits, was quite low; the shared variance for their 
correlation was less than 10% (r = .29, r2 = .08). This finding suggests that the ratio of 
opioid overdoses resulting in ED visits relative to mortality is likely to vary considerably by 
county. This variation may be attributed, at least in part, to the availability and accessibility 
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of EDs and to the willingness of any bystanders who witness the overdose either to call 911 
or to transport the overdosing individual to an ED. Take-home naloxone distribution was not 
widespread in North Carolina in 2012, eliminating the likelihood that this could explain the 
discrepancy. In that regard, North Carolina’s Good Samaritan Law (SB20/S.L.2013-23), 
enacted in 2013, should be particularly helpful, as it removed the threat of criminal liability 
from individuals who report an opioid overdose. A particularly low ratio of county-level ED 
visits to mortality related to overdoses may indicate the need to increase access to 
emergency services, increase awareness of these services if they are indeed available, or 
publicize the provisions of the Good Samaritan law to encourage prompt reporting.
It is also possible that the types of poisonings that result in ED visits rather than in death 
differ, to the extent that young children and women are more likely than adult males to visit 
EDs following an overdose. Furthermore, like incidents of drowning or suffocation, opioid 
overdose events may result in a death or, if they are successfully treated in the community, 
people who overdose may refuse further medical assistance. Their risk of mortality from a 
subsequent overdose may then increase. Finally, it is entirely possible that overdoses 
resulting in deaths receive much more publicity—and thus public attention—than those that 
result in ED visits. If so, relative to morbidity, mortality would be more likely to raise 
community awareness and stimulate action. These various explanations are at best tentative 
and are thus deserving of empirical investigation.
Our study’s second hypothesis was also partially confirmed. That is, we found a positive 
relationship between health directors’ total CR scores and RWJF’s indicator of their 
county’s overall health outcomes and health factors. As might be expected, healthy 
communities seem generally prepared to take action to promote their health. On the other 
hand, our finding suggests the need to pay particular attention to building readiness to 
change in communities that rank low on health indicators, if efforts to plan and implement 
opioid overdose prevention strategies are to be successful. Understanding how ready a 
community is to address a particular issue is important for anyone concerned with health and 
community development. A community cannot be expected to address a public health–
related problem until it recognizes the gravity of the problem. Tools such as the Tri-Ethnic 
Center’s CR model provide suggestions about activities that will increase the readiness of a 
community for each stage. Paired with Project Lazarus and other related substance abuse 
prevention capacity-building models, these tools can guide community members and leaders 
to develop stage-appropriate strategies and leverage available resources.
Because we were concerned that the strength of the associations we found might be an 
artifact of the number of duplicated CR scores (9 of the78 counties represented in the data 
set), we conducted an ex post facto analysis to reexamine the strength and range of these 
associations, by pooling county populations and outcome counts. As expected, we found that 
the magnitude of the associations tested changed minimally, demonstrating a slight increase 
in the magnitude of our key association of interest, between mean CR scores and overdose 
ED visit rates (.12 vs. the original .09, with no change in significance).
We note two other implications of our study’s findings. They provide modest initial support 
for our adaptation of the Tri-Ethnic Center scale for research use, in which we limited the 
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number of informants to one per county (its health director) and administered the instrument 
by means of a hierarchical list of response options. However, our adaptation of the scale 
should be subjected to further study and validation before it is considered for widespread 
use. We should also note the very high association between the pair of measures we used to 
assess RWJF’s county-level health indicators (outcomes and factors), which yielded a 
coefficient of .87. These findings suggest that for our purposes we could have selected one 
of this pair almost arbitrarily and achieved the same results.
In addition, our findings have implications for other research on community-based health 
promotion efforts. Community-randomized trials of community-based interventions in drug 
abuse rely on baseline characteristics of a community to compare intervention and control 
settings (Shapiro et al., 2013; Shapiro, Oesterle, & Hawkins, 2015). The CR tool adapted for 
our study could serve as a useful adjunct to others trying to understand the differences 
between communities with and without successfully implemented interventions.
LIMITATIONS
We acknowledge several limitations to this study. First, we employed only one reporter per 
county (i.e., its health director), while the Tri-Ethnic Center suggest the need for multiple 
reporters for each CR assessment. However, that was impractical for a study as large as ours. 
We believe that if we were limited to one, the health director would be the reporter of choice 
as the individual best qualified to understand the context of the community under her or his 
jurisdiction with regard to readiness to implement opioid overdose prevention strategies. 
Second, and as mentioned in the Measures section, we modified the data collection methods 
specified by the Tri-Ethnic Center so that we could measure the CR scale in a survey format, 
using one informant per county, as opposed to administering open-ended questions to 
multiple informants in each by means of interviews. While we believe that our adaptation 
was appropriate for this relatively large scale study, our findings may well have been 
different had we used the methods suggested by the Center. Third, we did not secure 
responses from all the health directors surveyed, so that our findings should not be 
considered as fully representative of the entire state of North Carolina. Fourth, as previously 
discussed, the jurisdictions of five of the health directors encompassed multiple (either two 
or three) contiguous counties, and we duplicated their CR scores across all the counties in 
their jurisdiction. It is thus entirely possible that CR scores would have varied across the 
counties within each jurisdiction had our respondents rated each of them individually. 
However, these jurisdictions tended to encompass rural counties with low populations; they 
averaged a population of 29,778 (SD = 19,067), which may be compared to the state’s 
average county-level population of 103,094 (SD = 161,665). Thus, the CR scores of the 
individual counties within each multicounty jurisdiction may have been unlikely to vary 
substantially, even if they had been individually rated. We also note that in operationalizing 
communities as specific counties we were unable to control for the fact that the State’s larger 
counties comprised multiple communities of greatly varying sizes. However, we believe that 
the likely social and cultural heterogeneity of the larger counties would have been more 
likely to generate a Type II than a Type 1 error, mitigating against finding the effects 
reported.
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Finally, the regression models made an assumption that neighboring communities’ scores 
and overdose rates would not have a direct influence on any given county. Testing this 
assumption is beyond the scope of this article, but it represents an area for further research. 
Finally, we recognize that the overall relationship we reported between CR and opioid 
overdose mortality, while significant, was modest. That may be a function of our CR 
questions, which related directly to prescription drug abuse, while our mortality data 
encompassed overdoses attributable to both prescription drugs and Schedule 1 (i.e., illegal) 
opioids.
CONCLUSIONS
CR is generally considered a prerequisite to the effective adoption and implementation of 
community-based strategies designed to address local public health problems. In this study 
we applied the concept of CR to the community-based implementation of drug overdose 
prevention programs in North Carolina as of 2012 and found that it was positively associated 
with opioid overdose–related mortality. Thus, all other things being equal, the counties with 
the greatest opioid misuse problems appear to be the most prepared to respond to them.
This finding suggests that community-based practitioners who seek to support and promote 
the effective adoption and implementation of local opioid overdose prevention strategies 
should consider mechanisms to increase CR. As specified by Goodman, Wandersman, 
Chinman, Imm, and Morrissey (1996), the first stage of CR entails the mobilization of 
community members and organizations. We suggest that this mobilization can best be 
effected by means of a campaign to raise public awareness of the extent of opioid misuse 
within the community, by sharing information concerning local statistics concerning 
overdose-related morbidity and mortality through social media and at community meetings. 
As increasing attention is paid to the importance of reducing stigma that remains attached to 
opioid use disorders (Olsen & Sharfstein, 2014), more families may be willing to disclose 
secrets that were once taboo—for example, by means of obituaries—concerning family 
members who have succumbed to opioid addiction. In so doing, a once hidden problem is 
likely to generate public action.
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TABLE 1
Dimensions of the Community Readiness for Prescription Drug Abuse Prevention Scale
Dimension Question Response Options (1–9)
Community climate What is the community climate 
around prescription drug abuse?
1 The community does not see prescription drug abuse as a problem. It 
is an accepted part of community life. “It’s just the way things are.”
9 All major segments of the community are highly supportive, and 
community members are actively involved in evaluating and 
improving efforts and demand accountability.
Knowledge about the 
issue
What is your community’s 
knowledge level about the problem 
of prescription drug abuse?
1 It is not viewed as a problem.
9 Specific information about the problem is being used to target high-
risk groups and plan the types of prevention programs needed. 
Information about the effectiveness of local programs is available.
Leadership What level of involvement do local 
leaders (health, political, religious, 
tribal, etc.) have in prevention 
programming for prescription drug 
abuse?
1 Leadership is resistant to prevention efforts.
9 Authorities support multiple efforts, staff are highly trained, 
community leaders and volunteers are involved, and an independent 
evaluation team is functioning.
Existing efforts What is the current state of 
prescription drug abuse prevention 
programming in your community?
1 Prevention is not important.
9 Evaluations plans are routinely used to test effectiveness of many 
different efforts, and the results are being used to make changes and 
improvements.
Community 
knowledge of efforts
What is your community’s level of 
knowledge of prescription drug 
abuse prevention efforts?
1 Community has no knowledge of the need for efforts addressing the 
issue.
9 Community has accurate knowledge based on thorough evaluation 
data about how well the different local efforts are working, their 
benefits and limitations.
Resources What is your community’s attitude 
about supporting prescription drug 
overdose prevention efforts with 
resources: people, money, time, or 
space?
1 There is no need for resources to deal with this problem.
9 There is continuous and secure support for basic programs and 
activities, evaluation is routinely expected and completed, and there 
are substantial resources for trying new efforts.
SOURCE: Plested, Edwards, and Jumper-Thurman (2006).
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